| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Meaney William L | President and CEO, Director | C/O IRON MOUNTAIN INCORPORATED, 85 NEW HAMPSHIRE AVENUE, SUITE 150, PORTSMOUTH | /s/ Christine Zhang, under Power of Attorney dated February 27, 2025, from William Meaney | 03 Mar 2026 | 0001566391 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRM | Common Stock, par value $.01 per share | Options Exercise | $0 | +650,674 | $0.000000 | 650,674 | 01 Mar 2026 | Direct | F1 | |
| transaction | IRM | Common Stock, par value $.01 per share | Tax liability | $27,736,813 | -256,040 | -39% | $108.33 | 394,634 | 01 Mar 2026 | Direct | F2 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $313,872 | -2,929 | -0.74% | $107.16 | 391,705 | 02 Mar 2026 | Direct | F3, F4 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $1,491,744 | -13,778 | -3.5% | $108.27 | 377,927 | 02 Mar 2026 | Direct | F3, F5 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $4,067,875 | -37,296 | -9.9% | $109.07 | 340,631 | 02 Mar 2026 | Direct | F3, F6 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $4,562,233 | -41,456 | -12% | $110.05 | 299,175 | 02 Mar 2026 | Direct | F3, F7 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $354,368 | -3,200 | -1.1% | $110.74 | 295,975 | 02 Mar 2026 | Direct | F3, F8 |
| transaction | IRM | Common Stock, par value $.01 per share | Options Exercise | $1,423,538 | +38,474 | +13% | $37.00 | 334,449 | 02 Mar 2026 | Direct | F3 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $224,104 | -2,076 | -0.62% | $107.95 | 332,373 | 02 Mar 2026 | Direct | F3, F9 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $1,792,332 | -16,457 | -5% | $108.91 | 315,916 | 02 Mar 2026 | Direct | F3, F10 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $1,993,232 | -18,117 | -5.7% | $110.02 | 297,799 | 02 Mar 2026 | Direct | F3, F11 |
| transaction | IRM | Common Stock, par value $.01 per share | Sale | $201,807 | -1,824 | -0.61% | $110.64 | 295,975 | 02 Mar 2026 | Direct | F3, F12 |
| holding | IRM | Common Stock, par value $.01 per share | 82,970 | 01 Mar 2026 | By Meaney 2024 Master Trust | ||||||
| holding | IRM | Common Stock, par value $.01 per share | 212,680 | 01 Mar 2026 | By Meaney Master Trust #2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRM | Performance Units | Options Exercise | $0 | -650,674 | -100% | $0.000000 | 0 | 01 Mar 2026 | Common Stock, par value $.01 per share | 650,674 | Direct | F13, F14 | |
| transaction | IRM | Employee Stock Option (Right to Buy) | Award | +74,069 | 74,069 | 01 Mar 2026 | Common Stock, par value $.01 per share | 74,069 | $108.33 | Direct | F15, F16 | |||
| transaction | IRM | Employee Stock Option (Right to Buy) | Options Exercise | -38,474 | -10% | 346,266 | 02 Mar 2026 | Common Stock, par value $.01 per share | 38,474 | $37.00 | Direct | F3, F16, F17 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This acquisition is reported to reflect the full vesting of performance units ("PUs") previously granted to the Reporting Person on March 1, 2023. Effective February 16, 2026, the Compensation Committee of Iron Mountain Incorporated (the "Company")'s Board of Directors determined the actual award of PUs under the grant after completion of the relevant performance period, and the PUs fully vested on March 1, 2026. |
| F2 | Represents the number of shares of Common Stock that have been withheld by the Issuer to satisfy its income tax withholding obligation in connection with the net settlement of the PUs and does not represent a sale. |
| F3 | The transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. |
| F4 | The price reported in Column 4 is a weighted average price. These shares of the Company common stock ("Common Stock") were sold in multiple transactions at prices ranging from $106.65 to $107.64, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4). |
| F5 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $107.67 to $108.66, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5). |
| F6 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $108.67 to $109.66, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (6). |
| F7 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $109.68 to $110.58, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (7). |
| F8 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $110.70 to $110.79, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (8). |
| F9 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $107.35 to $108.35, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (9). |
| F10 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $108.39 to $109.36, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (10). |
| F11 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $109.40 to $110.40, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (11). |
| F12 | The price reported in Column 4 is a weighted average price. These shares of Common Stock were sold in multiple transactions at prices ranging from $110.40 to $110.81, inclusive. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (12). |
| F13 | Each PU represents a contingent right to receive one share of Common Stock. |
| F14 | The PUs were initially granted to the Reporting Person on March 1, 2023. Effective as of February 16, 2026, the Compensation Committee determined the actual award of PUs under the grant after completion of the relevant performance period, and the PUs fully vested on March 1, 2026. |
| F15 | This stock option becomes exercisable in three substantially equal annual installments beginning on the first anniversary of the date of grant. |
| F16 | Not applicable. |
| F17 | This stock option, initially representing a right to purchase a total of 461,696 shares, is fully vested. |